ST AIA-PACK PAP
ST AIA-PACK PAP is designed for in-vitro
Part #: 0025262
Manufacturers:
Description
Prostrate cancer is the second most common type of cancer found in male. PAP concentrations were found to be elevated in many men with primary prostatic carcinoma and metastatic lesions of the prostate. Thus it was suggested that PAP may be significant tumor marker. PAP is released into the blood stream by the primary tumors or following relapse of a prostatic malignancy. Therefore, sensitive and accurate measurement of serum PAP is essential in monitoring the effectiveness of therapy.
Technical specifications
| Kit name | ST AIA-PACK PAP |
| Method | Enzyme Immunoassay (EIA) |
| Assay principle | Two-site immunoenzymometric assay |
| Assay sample | Serum or heparinized plasma |
| Calibrators | 0, 20 ng/mL |
| Standardization | Internal |
| Calibration stability | 90 days |
| Assay range | 0.2 - 40 ng/mL |
| Reaction time | 10 minutes |
| Hook effect | >9,000 ng/mL |
| Storage | 2 - 8oC |
Refer to the product Instruction-For-Use (IFU) for complete details.